Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
. Yannick Landais of the ISM Laboratory in Bordeaux. He/she will hold a PhD degree, preferably with expertise in Polymer Science. Where to apply Website https://emploi.cnrs.fr/Offres/CDD/UMR5629-DANTAT-011
-
2 Apr 2026 Job Information Organisation/Company CNRS Department Centre de Nanosciences et de Nanotechnologies Research Field Engineering Physics Technology Researcher Profile First Stage Researcher
-
). These structural features will be finely tuned with the controlled introduction of conformational defects and bulkier side groups to limit interactions. • Strong emphasis will be placed on increasing the molecular
-
researcher will join the ANR SCHEMA project team, which brings together researchers, research engineers, and PhD students from various laboratories and disciplines (LPG, IPAG, LaMPEA, LAPCOS, MONARIS
-
research centre dedicated to understanding normal and pathological brain function and developing new diagnostic and therapeutic approaches. Website: https://neurosciences.univ-grenoble-alpes.fr You will be
-
» Biological engineering Researcher Profile First Stage Researcher (R1) Application Deadline 3 Apr 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer
-
join a multidisciplinary research team at the interface between physics, engineering, and clinical research, including scientists, engineers, physicians, and PhD students. The position involves close
-
31 Jan 2026 Job Information Organisation/Company CNRS Department Expression Génétique Microbienne Research Field Chemistry Physics » Biophysics Biological sciences » Biological engineering
-
fluids, from sample preparation and enrichment strategies through targeted MS acquisition to data analysis and quality control. You will explore and benchmark different workflows on state-of-the-art
-
AIix-Marseille University/A*MIDEX | Marseille, Provence Alpes Cote d Azur | France | about 2 months ago
determinants underlying natural catalytic strategies of drug-target heme enzymes and their bioresistance. Our approach of engineering redox-active Trp(s) resulting in controlled Trp radical(s) as substrate